Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2025
Phase I clinical trial of the bifunctional EGFR/TGF-β fusion protein ficerafusp alfa (BCA101) alone and in combination with pembrolizumab for advanced solid tumorsAlberto Hernando-Calvo, Richard D Carvajal, Paul K Paik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumoursD S Boss, G K Schwartz, M R Middleton, et al.
Cancer|January 19, 2012
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention studyAngelo E Volandes, Tomer T Levin, Susan Slovin, et al.
The Oncologist|September 29, 2025
Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patientsTristan L Lim, Kamaneh Montazeri, Eric Wehrenberg-Klee, et al.
American Journal of Clinical Oncology|October 14, 2009
Radiotherapy after surgical resection for head and neck mucosal melanomaAbraham J Wu, Jennifer Gomez, Joanne E Zhung, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
British Journal of Cancer|January 9, 2023
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanomaS Piperno-Neumann, M S Carlino, V Boni, et al.
The Oncologist|May 10, 2015
A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain MetastasesJames J Harding, Federica Catalanotti, Rodrigo R Munhoz, et al.
Bioinformatics Advances|May 15, 2026
20 Years of the ISCB Student Council Symposium: shaping computational biology and future leadersMiguel Fernandez-Martin, Ana Castillo-Orozco, Miriam Poley-Gil, et al.
Cell Reports. Medicine|April 16, 2025
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecificJoseph J Sacco, Peter Kirk, Emma Leach, et al.
Pageof 22